Protein kinase C-ε is involved in the adenosine-activated signal transduction pathway conferring protection against ischemia-reperfusion injury in primary rat neuronal cultures

Journal of Neurochemistry

Volumn 84, Issue 2, 2003, Pages 409-412

  Di Capua, Noam ^a   Sperling, Oded ^a   Zoref Shani, Esther ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adenosine; Bisindolylmaleimide I; Ischemia reperfusion; Protein kinase C translocation inhibitor peptide ( V1 2); Protein kinase C ; Signal transduction pathway

Indexed keywords

ADENOSINE; MALEIMIDE; PROTEIN KINASE C EPSILON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL DEATH; CELL FRACTIONATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART MUSCLE CELL; MEDIATOR RELEASE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME ACTIVATORS; ENZYME INHIBITORS; IODOACETATES; ISOENZYMES; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; RATS; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALIA; INSERTION SEQUENCES;

EID: 0037265975     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01563.x     Document Type: Article

References (20)

1. Baxter G. F. (2002) Role of adenosine in delayed preconditioning of myocardium. Cardiovas. Res. 55, 483-494.
2. Baxter G. F., Goma F. M. and Yellow D. M. (1995). Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br. J. Pharmacol. 115, 222-224.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Dutil E. M. and Newton A. C. (2000) Dual role of pseudosubstrate in the coordinated regulation of protein kinase C by phosphorylation and diacylglycerol. J. Biol. Chem. 275, 10697-10701.
5. Hara H., Onodera H., Yoshidomi M. and Kogure K. (1990) Staurosporine, a novel protein kinase C inhibitor, prevents postischemic neuronal damage in the gerbil and rat. J. Cereb. Blood Flow Metab. 10, 643-653.
6. Huang H. M., Weng C. H., Ou S. C. and Hwang T. (1999) Selective subcellular redistributions of protein kinase C isoforms by chemical hypoxia. J. Neurosci. Res. 56, 668-678.
7. Johnson J. A., Gray M. O., Chen C. H. and Mochly-Rosen D. (1996) A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J. Biol. Chem. 271, 24962-24966.
8. Liu Y., Cohen M. V. and Downey J. M. (1994) Chelerythine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts [letter]. Cardiovas. Drug Ther. 8, 881-882.
9. Liu G. S., Cohen M. V., Mochly-Rosen D. and Downey J. M. (1999) Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 10, 1937-1948.
10. Mackay K. and Mochly-Rosen D. (2001) Arachidonic acid protects neonatal rat cardiac myocytes from ischaemic injury through epsilon protein kinase C. Cardiovasc. Res. 50, 65-74.
11. Maher P. (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21, 2929-2938.
12. Mullane K. (1992) Myocardial preconditioning. Circulation 85, 845-847.
13. Nishizuka Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614.
14. Pavlakovitc G., Eyer C. L. and Isom G. E. (1995) Neuroprotective effects of PKC inhibition against chemical hypoxia. Brain Res. 676, 205-211.
15. Qiu Y., Ping P., Tang X. L., Manchikalapudi S., Rizvi A., Zhang J., Takano H., Wu W. J., Teschner S. and Bolli R. (1998) Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J. Clin. Invest. 101, 2182-2198.
16. Reshef A., Sperling O. and Zoref-Shani E. (2000) The adenosine-induced mechanism for the acquisition of ischemic tolerance in primary rat neuronal cultures. Pharmacol. Therapeut. 87, 151-159.
17. Schulz R., Cohen M. V., Behrends M., Downey J. M. and Heusch G. (2001) Signal transduction of ischemic preconditioning. Cardiovasc. Res. 52, 181-198.
18. Tauskela J. S., Chakravarthy B. R., Murray C. L., Wang Y., Comas T., Hogan M., Hakim A. and Morley P. (1999) Evidence from cultured rat cortical neurons of differences in the mechanism of ischemic preconditioning of brain and heart. Brain Res. 827, 143-151.
19. Toullee D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E. and Loriolle F. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781.
20. Yedovitzky M., Mochly-Rosen D., Johnson J. A., Gray M. O., Ron D., Abramovitch E., Cerasi E. and Nesher R. (1997) Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. J. Biol. Chem. 272, 1417-1420.